Barclays Maintains Overweight on Exelon, Raises Price Target to $44
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Nicholas Campanella maintains an Overweight rating on Exelon (NASDAQ:EXC) and raises the price target from $41 to $44.
October 15, 2024 | 6:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays analyst Nicholas Campanella has maintained an Overweight rating on Exelon and increased the price target from $41 to $44, indicating a positive outlook.
The increase in price target from $41 to $44 by Barclays suggests a positive outlook for Exelon's stock, likely leading to a short-term price increase. The Overweight rating indicates confidence in the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100